• Home
  • Get Involved
  • Our Discoveries
    • At A Glance Summaries
    • Podcasts
    • Publications List
  • Upcoming Events
  • Protecting your data
  • About us

Perceptions over biologics for psoriasis after 5 years of access in Brazil: a cross-sectional study

by | Feb 25, 2026

Perceptions over biologics for psoriasis after 5 years of access in Brazil: a cross-sectional studyLeite, L. L., de Carvalho, A. V. E. & Smith, C., 25 Feb 2026, (E-pub ahead of print) In: JOURNAL OF DERMATOLOGICAL TREATMENT. 37, 1, 2627719.Research output:...

Correction to Prevalence of atopic dermatitis in the United States from 2021 to 2024: Data from the National Health Interview Survey [Journal of the American Academy of Dermatology 2026 Feb;94(2)633-635]

by | Feb 24, 2026

Correction to Prevalence of atopic dermatitis in the United States from 2021 to 2024: Data from the National Health Interview Survey [Journal of the American Academy of Dermatology 2026 Feb;94(2)633-635]Chan, K. R., Keddie, S. H., Flohr, C. & Tsoi, M. F., 24 Feb...

Integrated Methylome-Transcriptome Analysis Reveals Epigenomic Remodeling and Rho GTPase-Linked Immune-Epithelial Crosstalk in Atopic Dermatitis

by | Feb 17, 2026

Integrated Methylome-Transcriptome Analysis Reveals Epigenomic Remodeling and Rho GTPase-Linked Immune-Epithelial Crosstalk in Atopic DermatitisMAARS Consortium, 17 Feb 2026, (E-pub ahead of print) In: Allergy.Research output: Contribution to journal › Article ›...

An Antibody-Drug Conjugate Designed Through Clone and Isotype Selection Restricts the Growth of CSPG4-Expressing Triple-Negative Breast Cancer

by | Feb 16, 2026

An Antibody-Drug Conjugate Designed Through Clone and Isotype Selection Restricts the Growth of CSPG4-Expressing Triple-Negative Breast CancerEsapa, B., Liu, Y., Chenoweth, A., Stoker, K., Łabędź, N., Romero Clavijo, P., Ilieva, K., Trendell, J., Navarro-Llinas, B.,...

Pharmacokinetic-pharmacodynamic modelling of risankizumab using chronic plaque psoriasis real-world data

by | Feb 15, 2026

Pharmacokinetic-pharmacodynamic modelling of risankizumab using chronic plaque psoriasis real-world dataThomas, C. M., Wei, J. R., Baudry, D., Arkir, Z., Coker, B., Dasandi, T., Powell, K., Arenas-Hernandez, M., Leung, J., Rawstron, K., Nwaogu, C., Woolf, R., Pink, A....
« Older Entries
Next Entries »

Recent Posts

    Recent Comments

    No comments to show.

    Our studies

    PLAN

    JAKPPPOT

    mySkin

    BEACON

    MISST

    Alopecia & Us

    Contact us

    To contact study teams directly please visit their specific page use the contacts details provided.

    © 2025 St John’s Research